Immune Checkpoint Inhibitors Ici | List of Frontiers open access articles

Case Report

Published on 09 Aug 2022

Successful immune checkpoint inhibitor rechallenge after immune-related pericarditis: Clinical case series

in Cardio-Oncology

Adrian M. Chye
Ina I. C. Nordman
Aaron L. Sverdlov

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.964324

2,988 views
4 citations

Original Research

Published on 16 Nov 2021

Age-Based Disparities in Metastatic Melanoma Patients Treated in the Immune Checkpoint Inhibitors (ICI) Versus Non-ICI Era: A Population-Based Study

in Cancer Immunity and Immunotherapy

Mohammed Safi
Mahmoud Al-Azab
Chenxing Jin
Dario Trapani
Salem Baldi
Salah Adlat
Aman Wang
Bashir Ahmad
Hamza Al-madani
Xiu Shan

Frontiers in Immunology

doi 10.3389/fimmu.2021.609728

5,592 views
12 citations

Review

Published on 18 Apr 2023

Methods for assessment of the tumour microenvironment and immune interactions in non-small cell lung cancer. A narrative review

in Thoracic Oncology

Kanishka Rangamuwa
Christian Aloe
Michael Christie
Marie-Liesse Asselin-Labat
Daniel Batey
Lou Irving
Thomas John
Steven Bozinovski
Tracy L. Leong
Daniel Steinfort

Frontiers in Oncology

doi 10.3389/fonc.2023.1129195

5,977 views
6 citations

Review

Published on 27 Jul 2018

Combining Immune Checkpoint Inhibitors With Conventional Cancer Therapy

in Cancer Immunity and Immunotherapy

Yiyi Yan
Anagha Bangalore Kumar
Heidi Finnes
Svetomir N. Markovic
Sean Park
Roxana S. Dronca
Haidong Dong

Frontiers in Immunology

doi 10.3389/fimmu.2018.01739

24,360 views
202 citations

Review

Published on 14 Oct 2020

Glioblastoma Immune Landscape and the Potential of New Immunotherapies

in Cancer Immunity and Immunotherapy

Thomas Daubon
Audrey Hemadou
Irati Romero Garmendia
Maya Saleh

Frontiers in Immunology

doi 10.3389/fimmu.2020.585616

27,541 views
99 citations

Case Report

Published on 18 Jun 2021

Pembrolizumab-Induced Thyroiditis Shows PD-L1Expressing Histiocytes and Infiltrating T Cells in Thyroid Tissue - A Case Report

in Autoimmune and Autoinflammatory Disorders

Jörg Jabkowski
Almute Loidl
Barbara Auinger
Helmut Kehrer
Norbert Sepp
Robert Pichler

Frontiers in Immunology

doi 10.3389/fimmu.2021.606056

5,246 views
9 citations

Review

Published on 12 Oct 2021

Targeting DNA Repair Response Promotes Immunotherapy in Ovarian Cancer: Rationale and Clinical Application

in Cancer Immunity and Immunotherapy

Hongyu Xie
Wenjie Wang
Wencai Qi
Weilin Jin
Bairong Xia

Frontiers in Immunology

doi 10.3389/fimmu.2021.661115

7,208 views
11 citations

Review

Published on 28 Jan 2022

Inborn Errors of Immunity and Their Phenocopies: CTLA4 and PD-1

in Primary Immunodeficiencies

Yuwei Hao
Matthew C. Cook

Frontiers in Immunology

doi 10.3389/fimmu.2021.806043

10,154 views
13 citations

Review

Published on 03 Feb 2021

Radiotherapy and Immunotherapy for Head and Neck Cancer: Current Evidence and Challenges

in Radiation Oncology

Jack M. Qian
Jonathan D. Schoenfeld

Frontiers in Oncology

doi 10.3389/fonc.2020.608772

19,541 views
62 citations

Review

Published on 07 Sep 2023

Preclinical studies performed in appropriate models could help identify optimal timing of combined chemotherapy and immunotherapy

in Cancer Immunity and Immunotherapy

Yani Berckmans
Jolien Ceusters
Ann Vankerckhoven
Roxanne Wouters
Matteo Riva
An Coosemans

Frontiers in Immunology

doi 10.3389/fimmu.2023.1236965

4,159 views
4 citations

Case Report

Published on 20 Dec 2022

Case report: Eosinophilic fasciitis induced by pembrolizumab with high FDG uptake on 18F-FDG-PET/CT

in Nuclear Medicine

Karim Amrane
Coline Le Meur
Philippe Thuillier
Pierre Alemany
Clémence Niel
David Renault
Ronan Abgral

Frontiers in Medicine

doi 10.3389/fmed.2022.1078560

2,758 views
9 citations

Review

Published on 17 Aug 2022

Immune checkpoint inhibitors for PD-1/PD-L1 axis in combination with other immunotherapies and targeted therapies for non-small cell lung cancer

in Cancer Immunity and Immunotherapy

Ofek Mussafi
Jie Mei
Wenjun Mao
Yuan Wan

Frontiers in Oncology

doi 10.3389/fonc.2022.948405

6,655 views
14 citations

Case Report

Published on 06 Oct 2022

Immune myocarditis related to sintilimab treatment in a patient with advanced lung adenocarcinoma: A case report

in Cardio-Oncology

Yunling Lin
Xun Yuan
Lianglong Chen

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.955527

3,193 views
8 citations

Perspective

Published on 04 Jul 2024

Immunotherapy and radiotherapy for older patients with invasive bladder cancer unfit for surgery or chemotherapy: practical proposal by the international geriatric radiotherapy group

in Cancer Molecular Targets and Therapeutics

Nam Phong Nguyen
Ulf Lennart Karlsson
Brandi R. Page
Monica-Emilia Chirila
Vincent Vinh-Hung
Olena Gorobets
Meritxell Arenas
Mohammad Mohammadianpanah
Seyed Alireza Javadinia
Huan Giap

Frontiers in Oncology

doi 10.3389/fonc.2024.1371752

4,146 views

Review

Published on 29 May 2019

Can Immunogenic Chemotherapies Relieve Cancer Cell Resistance to Immune Checkpoint Inhibitors?

in Cancer Immunity and Immunotherapy

Thaiz Rivera Vargas
Lionel Apetoh

Frontiers in Immunology

doi 10.3389/fimmu.2019.01181

7,303 views
30 citations

Case Report

Published on 13 Nov 2024

Case report: Metastatic melanoma derived from a somatic-type malignant transformation of a mediastinal teratoma treated with immune checkpoint inhibitors

in Thoracic Oncology

Roberto Rosenfeld
Silvia Riondino
Giusy Parisi
Giovanni Maria Iannantuono
Rexhina Ajdhoni
Francesco Torino
Sabrina Mariotti
Mario Roselli

Frontiers in Oncology

doi 10.3389/fonc.2024.1417776

1,333 views
1 citation

Articles

Successful immune checkpoint inhibitor rechallenge after immune-related pericarditis: Clinical case series

Age-Based Disparities in Metastatic Melanoma Patients Treated in the Immune Checkpoint Inhibitors (ICI) Versus Non-ICI Era: A Population-Based Study

Methods for assessment of the tumour microenvironment and immune interactions in non-small cell lung cancer. A narrative review

Combining Immune Checkpoint Inhibitors With Conventional Cancer Therapy

Glioblastoma Immune Landscape and the Potential of New Immunotherapies

Pembrolizumab-Induced Thyroiditis Shows PD-L1Expressing Histiocytes and Infiltrating T Cells in Thyroid Tissue - A Case Report

Targeting DNA Repair Response Promotes Immunotherapy in Ovarian Cancer: Rationale and Clinical Application

Inborn Errors of Immunity and Their Phenocopies: CTLA4 and PD-1

Radiotherapy and Immunotherapy for Head and Neck Cancer: Current Evidence and Challenges

Preclinical studies performed in appropriate models could help identify optimal timing of combined chemotherapy and immunotherapy

Case report: Eosinophilic fasciitis induced by pembrolizumab with high FDG uptake on 18F-FDG-PET/CT

Immune checkpoint inhibitors for PD-1/PD-L1 axis in combination with other immunotherapies and targeted therapies for non-small cell lung cancer

Immune myocarditis related to sintilimab treatment in a patient with advanced lung adenocarcinoma: A case report

Immunotherapy and radiotherapy for older patients with invasive bladder cancer unfit for surgery or chemotherapy: practical proposal by the international geriatric radiotherapy group

Can Immunogenic Chemotherapies Relieve Cancer Cell Resistance to Immune Checkpoint Inhibitors?

Case report: Metastatic melanoma derived from a somatic-type malignant transformation of a mediastinal teratoma treated with immune checkpoint inhibitors